Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 6 of 45, showing 5 Applications out of 225 total, starting on record 26, ending on 30

# Protocol No Study Title Investigator(s) & Site(s) Application Status

26.

ECCT/13/04/03   HIV-Malaria Study_A5297
        An Open-Label, Proof of Concept, Randomized Trial Comparing a LPV/r-Based to an nNRTI-Based Antiretroviral Therapy Regimen for Clearance of    Plasmodium falciparum Subclinical Parasitemia in HIV-infected Adults with CD4+ Counts >200 and <350 cells/mm3 .   
Principal Investigator(s)
1. Josphat K. Kosgei
Site(s) in Kenya
1. Kemri Walter Reed Project-Kericho (Kericho county)
2. Moi University Clinical Research Centre (Uasin Gishu county)
 
Trial Status Analysing
Protocol Date 29-02-2012
View

27.

ECCT/19/03/02   PREVENT TD
    A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550 mg daily or 550 mg twice daily) for Chemoprophylaxis Against Travellers’ Diarrhoea (TD) Among Active Duty Deployed U.S. and British Military Personnel (PREVENT TD)   
Principal Investigator(s)
1. Flynn Alexander
Site(s) in Kenya
Nyati Barracks, British Army Training Unit, Kenya
 
Trial Status Stopped
Protocol Date 14-11-2016
View

28.

ECCT/17/06/01   MF/PM Phase III
    An Open Label, Phase III, Randomized Controlled, Multicentre Non-Inferiority Trial to Compare Efficacy and Safety of Miltefosine and Paromomycin with Sodium Stibogluconate and Paromomycin Combination for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa       
Principal Investigator(s)
1. Jane Mbui
Site(s) in Kenya
1. Kimalel Health Centre (Baringo county)
2. Kacheliba sub-county hospital (West Pokot county)
 
Trial Status In follow-up
Protocol Date 20-02-2017
View

29.

ECCT/10/09/05   A5225/ HiFLAC
    A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis       A Multicenter Trial of the AIDS Clinical Trials Group (ACTG)   
Principal Investigator(s)
1. Deborah Chepngeno langat
Site(s) in Kenya
1.
 
Trial Status Writing-up
Protocol Date 11-05-2012
View

30.

ECCT/19/10/02   AMC-100
    A Phase II Multicenter Study of Pomalidomide Monotherapy in HIV-Positive Individuals with Kaposi Sarcoma (KS) in Sub-Saharan Africa (SSA)   
Principal Investigator(s)
1. NAFTALI WISINDI BUSAKHALA
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH CENTER
 
Trial Status (not set!)
Protocol Date 07-05-2019
View